SCHEMBL2964355

SCHEMBL2964355

Cc1cc(Br)c(C2C=Cc3ccccc32)cc1C

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
SIGMAR1 Q99720 6/20 0.32
HTR6 P50406 1/20 0.31
HTR2A P28223 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2962076 0.89 SIGMAR1 (0.31) ALDH1A1SIGMAR1HTR6HTR2A
SCHEMBL2964360 0.82 SIGMAR1 (0.31) ALDH1A1SIGMAR1HTR6HTR2A
SCHEMBL2971027 0.81 HTR6 (0.32) SIGMAR1HTR6HTR2A
SCHEMBL2971830 0.81 CYP1A2 (0.42) ALDH1A1
SCHEMBL2972562 0.81 CYP1A2 (0.39) ALDH1A1
SCHEMBL2974353 0.80 SIGMAR1 (0.30) SIGMAR1
SCHEMBL2975776 0.80 CYP1A2 (0.31) SIGMAR1
SCHEMBL2963690 0.79 CYP2A6 (0.40)
SCHEMBL2963349 0.79 CYP2A6 (0.40)
SCHEMBL2970779 0.78 CFB (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
WO-2006065809-A2 HETEROATOM BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 ALDH1A1 4332/4885SIGMAR1 3249/4885HTR6 2737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.